Iridogoniodysgenesis, dominant type

From WikiMD's Food, Medicine & Wellness Encyclopedia

Autosomal dominant - en

Iridogoniodysgenesis, dominant type is a rare genetic disorder that affects the development of the iris and the anterior chamber of the eye. This condition is characterized by abnormalities in the iris and the trabecular meshwork, which can lead to glaucoma and other ocular complications.

Clinical Features[edit | edit source]

Individuals with iridogoniodysgenesis, dominant type, typically present with distinctive ocular features, including:

Genetics[edit | edit source]

Iridogoniodysgenesis, dominant type, is inherited in an autosomal dominant manner. This means that a single copy of the altered gene in each cell is sufficient to cause the disorder. The specific gene or genes involved in this condition are not yet fully understood, but it is known to be associated with mutations in genes that play a role in the development of the anterior chamber of the eye.

Diagnosis[edit | edit source]

The diagnosis of iridogoniodysgenesis, dominant type, is based on clinical examination and the identification of characteristic ocular features. Genetic testing may be used to confirm the diagnosis and to identify the specific genetic mutation responsible for the condition.

Management[edit | edit source]

Management of iridogoniodysgenesis, dominant type, focuses on monitoring and treating glaucoma and other ocular complications. This may include:

Prognosis[edit | edit source]

The prognosis for individuals with iridogoniodysgenesis, dominant type, varies depending on the severity of the condition and the effectiveness of glaucoma management. Early diagnosis and appropriate treatment are crucial in preventing vision loss and other complications.

Related Pages[edit | edit source]

Categories[edit | edit source]


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD